scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.WNEU.2017.01.083 |
P698 | PubMed publication ID | 28153617 |
P2093 | author name string | Jie Luo | |
Qianxue Chen | |||
Juntao Hu | |||
P2860 | cites work | Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease | Q87123847 |
The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality | Q87340542 | ||
Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development | Q24317590 | ||
A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. | Q34147943 | ||
Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. | Q34388898 | ||
The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization | Q34450594 | ||
Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population | Q34461040 | ||
Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey | Q34720010 | ||
The promise of minocycline in neurology. | Q35958974 | ||
Moyamoya disease: current concepts and future perspectives | Q37305024 | ||
Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? | Q40060007 | ||
Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. | Q40607050 | ||
Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres | Q44112798 | ||
Ablation of Rnf213 retards progression of diabetes in the Akita mouse | Q45164699 | ||
Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. | Q48014638 | ||
Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion | Q48087981 | ||
Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease | Q48263056 | ||
Epidemiological and clinical features of Moyamoya disease in Nanjing, China | Q48381792 | ||
Ultrastructural studies of cerebral arteries and collateral vessels in moyamoya disease | Q48651322 | ||
Histopathology of the brain vascular network in moyamoya disease | Q48810229 | ||
Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain | Q49052312 | ||
Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. | Q52597321 | ||
Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study. | Q53148379 | ||
Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine sing | Q53250907 | ||
Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. | Q53413414 | ||
Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. | Q53540015 | ||
Linkage of Familial Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis) to Chromosome 17q25 | Q57269479 | ||
Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. | Q59697640 | ||
Worldwide Distribution of Moyamoya Disease | Q67466822 | ||
Cerebral haemorrhage in Moyamoya disease at autopsy | Q70891849 | ||
Angiogenic factors in moyamoya disease | Q71905100 | ||
Moyamoya disease | Q73090978 | ||
Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model | Q73265468 | ||
Linkage analysis of moyamoya disease on chromosome 6 | Q73658136 | ||
Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow | Q73832982 | ||
Histological features of middle cerebral arteries from patients treated for Moyamoya disease | Q79632750 | ||
A novel susceptibility locus for moyamoya disease on chromosome 8q23 | Q80553325 | ||
Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease | Q80968092 | ||
Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease | Q83193829 | ||
Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: a case-control study | Q83474001 | ||
Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) | Q84745917 | ||
Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study | Q84933149 | ||
P304 | page(s) | 731-741 | |
P577 | publication date | 2017-01-30 | |
P1433 | published in | World Neurosurgery | Q26853866 |
P1476 | title | The Susceptibility Pathogenesis of Moyamoya Disease | |
P478 | volume | 101 |
Q91716470 | Clinical efficacy of extracranial-intracranial bypass for the treatment of adult patients with moyamoya disease: A protocol of systematic review of randomized controlled trials |
Q57170001 | MinION rapid sequencing: Review of potential applications in neurosurgery |
Q55340113 | Moyamoya disease in a Moroccan baby: a case report. |
Q88413676 | Noninvasive Assessment of Hemodynamic Stress Distribution after Indirect Revascularization for Pediatric Moyamoya Vasculopathy |
Q58608274 | Proximal internal carotid artery stenosis associates with diffuse wall thickening in petrous arterial segment of moyamoya disease patients: a three-dimensional magnetic resonance vessel wall imaging study |
Q98466910 | RNF213 gene polymorphism rs9916351 and rs8074015 significantly associated with moyamoya disease in Chinese population |
Search more.